Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, actinomycin-d, etoposide, cisplatin (EMA/EP)
暂无分享,去创建一个
L. Özkan | T. Bilgin | H. Ozan | S. Özuysal
[1] S. Sekiya,et al. Adjuvant Hysterectomy in Low‐Risk Gestational Trophoblastic Disease , 2001, Obstetrics and gynecology.
[2] M. Seckl,et al. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] S. J. Kim,et al. Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen. , 1998, Gynecologic oncology.
[4] E S Newlands,et al. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] E. Lehman,et al. Salvage surgery for chemorefractory gestational trophoblastic disease. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] A. Ayhan,et al. Pregnancy after chemotherapy for gestational trophoblastic disease. , 1990, The Journal of reproductive medicine.
[7] A. Altintaş,et al. Central nervous system involvement in gestational trophoblastic neoplasia. , 2001, European journal of gynaecological oncology.